Favorable Outcomes in Elderly Patients Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma

High-dose therapy and autologous stem cell transplantation (HDT-ASCT) can offer potential long-term remission or cure in patients with non-Hodgkin lymphoma (NHL). Limited experience is available on the safety and efficacy of HDT-ASCT in elderly patients. This is a single-center, retrospective study...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Biol Blood Marrow Transplant
Asıl Yazarlar: Dahi, Parastoo B., Tamari, Roni, Devlin, Sean M., Maloy, Molly, Bhatt, Valkal, Scordo, Michael, Goldberg, Jenna, Zelenetz, Andrew D., Hamlin, Paul A., Matasar, Matthew J., Maragulia, Jocelyn, Giralt, Sergio A., Perales, Miguel-Angel, Moskowitz, Craig H., Sauter, Craig S.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5480286/
https://ncbi.nlm.nih.gov/pubmed/25175794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.08.019
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller